Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
2420
result was found. Results
Efficacy and safety of antihypertensive drugs combined with folic acid in treating hypertension with hyperhomocysteinemia: a systematic review and Meta-analysis
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1010-1024.
1933 times
402 times
LONG Zhiping
WANG Changwen
SUN Fanfan
XU Shibo
YAN Junzhen
ZENG Cheng
Antihypertensive drugs
Folic acid
Hypertension
Hyperhomocysteinemia
Meta-analysis
Randomized controlled trials
Details
Research progress on active ingredients of traditional Chinese medicine in preventing and treating ischemic heart disease based on mitochondrial dynamics regulation
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1036-1046.
2028 times
372 times
ZHOU Miao
WEI Lei
LI Maxizi
TIAN Silan
WANG Yinmei
Ischemic heart disease
Mitochondrial dynamics
Active ingredients of traditional Chinese medicine
Mitophagy
Myocardial ischemia-reperfusion injury
Details
Analysis of control strategies for nitrosamine drug substance-related impurities
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1047-1056.
1812 times
344 times
LI Hao
QI Qiancheng
ZHANG Shuai
SUN Caixia
Nitrosamine drug substance-related impurities
Control strategies
Risk assessment
Limit determination
Analytical methods
Elimination strategies
Details
Research status of quality control for medicinal plants of the Callerya
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1057-1065.
1916 times
475 times
XIAO Ling
WANG Yilan
Callerya
Callerya dielsiana
Callerya nitidavar. hirsutissima
Callerya speciosa
Quality standard
Research progress
Details
Research progress on chemical constituents, pharmacological effects and quality control of Swertia patens Burk.
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1066-1073.
1787 times
429 times
TIAN Shuxing
ZI Fayun
YANG Qiaoyan
SHI Xiufang
ZOU Lan
WANG Jimei
ZHANG Pan
Swertia patens Burk.
Chemical composition
Pharmacological effects
Quality control
Yi medicine
Details
Problems and countermeasures of scientific research drug dispensing management in medical instisutions
Published on
Frontiers in Pharmaceutical Sciences
2026,30(6):1074-1080.
2044 times
484 times
SHAO Xiyue
LI Rongqi
ZHOU Ziye
ZHANG Xiuhua
Medical Institutions
Basic research
Clinical research
Scientific drugs
Dispensing and management
Reflections
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (19): tool systems and methodological paradigms for common data model-based data analysis
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):721-731.
1029 times
332 times
WU Yunxiao
NIE Xiaolu
ZHENG Yongqi
WANG Conghui
WU Jiarui
SUN Yexiang
SONG Haibo
ZHAN Siyan
SUN Feng
Pharmacoepidemiology
Methodology
Guideline
Common data model
Real world evidence
Details
Influencing factors for unfavorable outcomes of doxycycline therapy in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):732-737.
1121 times
367 times
GAO Yufeng
WU Qiong
LIN Zhi
Doxycycline
Children
Macrolide-resistant
Mycoplasma pneumoniae pneumonia
Clinical outcome
Risk factors
Details
Efficacy of popliteal sciatic nerve block versus total intravenous anesthesia in diabetic foot surgery and analysis of influencing factors for wound healing
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):738-746.
893 times
296 times
YANG Yue
PENG Junbo
LU Xinlei
Diabetic foot
Popliteal sciatic nerve block
Intravenous anesthesia
Wound healing
Hemodynamics
Risk factors
Details
Long-term efficacy, safety, and risk stratification for hyperkalemia associated with finerenone in patients with diabetic kidney disease
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):747-756.
1073 times
350 times
XIE Yang
LI Lin
HAN Wenxia
Finerenone
Diabetic kidney disease
Real-world study
Linear mixed model
Urinary albumin-to-creatinine ratio
Risk stratification
Details
Impact of enhanced recovery after surgery intervention on postoperative recovery in patients undergoing colorectal cancer surgery treated with Bacillus licheniformis
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):757-764.
970 times
311 times
WANG Feifei
LU Xiaoyue
XU Dafang
Enhanced recovery after surgery
Bacillus licheniformis
Colorectal cancer
Postoperative recovery time
Perioperative nursing
Details
Clinical efficacy of Tianqi Jiangtang capsule combined with empagliflozin in newly diagnosed type 2 diabetes mellitus patients
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):765-772.
1022 times
349 times
SHI Jin
PEI Zijuan
ZHANG Dan
CHEN Dan
WANG Dandan
ZHANG Li
SHI Kaiyue
WANG Dan
XIE Muya
YAN Ying
Type 2 diabetes
Tianqi Jiangtang capsules
Empagliflozin
Blood sugar
Insulin
Details
Mining and analysis of adverse event signals for three novel lipoglycopeptide antibiotics based on the FAERS and WHO-VigiAccess database
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):773-782.
923 times
318 times
ZHANG Yao
HU Zhansong
ZHAO Xiaoyun
CHEN Lijuan
Lipoglycopeptide antibiotics
Adverse events
FAERS
WHO-VigiAccess
Signal mining
Details
Signal mining and analysis of adverse events of mirikizumab based on FAERS and EudraVigilance databases
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):783-791.
915 times
309 times
YAN Xu
SUN Kun
JI Zhaoshuai
NIE Guangmeng
Mirikizumab
Crohn's disease
Ulcerative colitis
FAERS
EudraVigilance
Signal mining
Details
Signal analysis of adverse events associated with pertuzumab-trastuzumab based on the FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(7):792-799.
976 times
275 times
ZHANG Juan
ZHU Haizhou
ZHANG Xue
GUO Kaixing
Pertuzumab-trastuzumab
FAERS database
Adverse drug events
Signal mining
Reporting odds ratio
Pharmacovigilance
Details
上一页
1
2
153
154
155
156
157
158
159
160
161
162
下一页